A recent in vivo study further found significantly higher CYP1A2 activity in carriers of the A503V TT haplotype after smoking cessation41, suggesting that POR A503V might be involved in smoking-mediated bladder cancer by decreasing CYP1A2 activity. The gene discussed is CYP1A2; the disease is urinary bladder carcinoma.